Literature DB >> 26842429

A practical divergence measure for survival distributions that can be estimated from Kaplan-Meier curves.

Trevor F Cox1, Gabriela Czanner2,3.   

Abstract

This paper introduces a new simple divergence measure between two survival distributions. For two groups of patients, the divergence measure between their associated survival distributions is based on the integral of the absolute difference in probabilities that a patient from one group dies at time t and a patient from the other group survives beyond time t and vice versa. In the case of non-crossing hazard functions, the divergence measure is closely linked to the Harrell concordance index, C, the Mann-Whitney test statistic and the area under a receiver operating characteristic curve. The measure can be used in a dynamic way where the divergence between two survival distributions from time zero up to time t is calculated enabling real-time monitoring of treatment differences. The divergence can be found for theoretical survival distributions or can be estimated non-parametrically from survival data using Kaplan-Meier estimates of the survivor functions. The estimator of the divergence is shown to be generally unbiased and approximately normally distributed. For the case of proportional hazards, the constituent parts of the divergence measure can be used to assess the proportional hazards assumption. The use of the divergence measure is illustrated on the survival of pancreatic cancer patients.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Kaplan-Meier curves; Kullback-Leibler divergence; crossing hazard functions; divergence measures; multidimensional scaling

Mesh:

Year:  2016        PMID: 26842429     DOI: 10.1002/sim.6868

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Two-sample survival probability curves: A graphical approach for the analysis of time to event data in clinical trials.

Authors:  Sandra Castro-Pearson; Chap T Le; Xianghua Luo
Journal:  Contemp Clin Trials       Date:  2022-02-14       Impact factor: 2.261

2.  Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).

Authors:  Manuel Montero-Odasso; Frederico Pieruccini-Faria; Robert Bartha; Sandra E Black; Elizabeth Finger; Morris Freedman; Barry Greenberg; David A Grimes; Robert A Hegele; Christopher Hudson; Peter W Kleinstiver; Anthony E Lang; Mario Masellis; Paula M McLaughlin; Douglas P Munoz; Stephen Strother; Richard H Swartz; Sean Symons; Maria Carmela Tartaglia; Lorne Zinman; Michael J Strong; William McIlroy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.